Logo.jpg
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16, 2024 18:15 ET | EUDA Health Holdings Limited
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating...
Logo.jpg
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16, 2024 17:29 ET | EUDA Health Holdings Limited
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The...
Logo.jpg
EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
October 05, 2023 09:00 ET | EUDA Health Holdings Limited
SINGAPORE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more...
Logo.jpg
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements
September 22, 2023 08:00 ET | EUDA Health Holdings Limited
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The...
Logo.jpg
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement
August 14, 2023 08:15 ET | EUDA Health Holdings Limited
Singapore, Aug. 14, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq...
Logo.jpg
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
August 04, 2023 08:30 ET | EUDA Health Holdings Limited
Singapore, Aug. 04, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a notice (the “MVLS Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that...
Euda Logo.jpg
8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination
November 23, 2022 16:32 ET | EUDA Health Holdings Limited
Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, today announced the completion of...
Logo 2.jpg
8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination
November 17, 2022 17:23 ET | 8i Acquisition 2 Corp
Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, today announced the completion of...
Logo 2.jpg
8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption
November 10, 2022 16:01 ET | 8i Acquisition 2 Corp
Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ: LAX, the “Company”), a special purpose acquisition company, announced today that all proposals presented to shareholders...
Logo 2.jpg
8i Acquisition 2 Corp. and EUDA Health Limited Announce Amendment to Share Purchase Agreement
June 10, 2022 16:15 ET | 8i Acquisition 2 Corp
Singapore, June 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited (“EUDA...